SCIENTIFIC PROGRAM
Day 01 | April 8, 2022 | Hall A
TimeTopicSession Chair/ Speakers
11:00 AM – 12:30 PM
(20 min talk & 10 min discussion) For debate- 10 min talk each and 10 mins discussion
Session I:
Leukemia
Session Chair:
Sanjeevan Sharma
11:00 AM – 11:30 AMHaplo identical HSCT for ALLRanjit Kumar Sahoo
11:30 AM – 12:00 PMMaintenance therapies vs DLI (Debate)Vivek Radhakrishnan vs Sachin Punantar
12:00 PM – 12:30 PMTMLI vs TBI (Debate)Srinivas Chilukuri (for TMLI);
Rimpa Achari (for TBI)
12:30 PM – 01:30 PMSponsored Symposium (Emcure)
Hall A
12.30 PM – 12.35 PMIntroduction
12:35 PM – 12:55 PMCMV Infection in HSCT – Real World ChallengesSachin Jhadav
12:55 – 01:15 PMPanel Discussion
CMV Infection in HSCT – Real World Challenges
Moderator
Sachin Jhadav
Panelists
Rahul Bhargava
Suraj Chiraniya
Pawan Kumar Singh
Sunil Bhat
01:15 PM – 01:30 PMDiscussion
12:30 PM – 01:30 PMSponsored Symposium (MSD)
Hall B
12.30 PM – 12.32 PMIntroductionAshutosh Kakade
12:32 PM – 01:20 PMPosaconazole DRT Prophylaxis of IFIM Joseph John
01:20 PM – 01:30 PMQ & A
01:15 PM – 01:30 PMDiscussion
01:30 PM – 01:45 PMBreak
01:45 PM – 02:00 PMInauguration
02:00 PM – 03:30 PM
(20 min talk & 10 min discussion each)
Session II:
Lymphoma / Myeloma
Session Chair:
Shashikant Apte
02:00 PM – 02:30 PMCAR-T in MyelomaSameer Melinkeri
02:30 PM – 03:00 PMAutograft for TNHLSharon Lionel
03:00 PM – 03:30 PMHaplo identical HSCT for Hodgkins LymphomaSaurabh Bhave
03:30 PM – 05:00 PM
(20 min talk & 10 min discussion each)
Session III:
Pediatric Session
Session Chair:
Prashant Hiwarkar
03:30 PM – 04:00 PMHaploidentical HSCT for Fanconi AnemiaGaurav Kharya
04:00 PM – 04:30 PMHSCT for HLHSatya Prakash Yadav
04:30 PM – 05:00 PMHaplo for HemoglobinopathiesSunil Bhat
05:00 PM – 06:30 PMPoster SessionJudges:
Punit Jain,
Ponni Sivaprakasam
Intezar Mehdi
06:30 PM – 08:00 PM
(20 min talk & 10 min discussion each)
Session IV:
Joint Session of ISBMT, APBMT and ASTCT
Session Chairs:
Mammen Chandy,
Shinichiro Okamoto,
Daniel Couriel
06:30 PM – 07:00 PMNovel Insights into Biology and Treatment of Acute GVHDTakanori Teshima, Japan
07:00 PM – 07:30 PMWithaferin A- A Medicinal Plant Derivative for Prevention and Treatment of Acute GVHDVikram Gota, India
07:30 PM – 08:00 PMNovel Insights into Biology & Treatment of Chronic GVHDDaniel Couriel, USA
SCIENTIFIC PROGRAM
Day 02 | April 9, 2022 | Hall A
TimeTopicSession Chair/ Speakers
08:00 AM – 09:00 AMMeet The Expert SessionExperts:
08:00 AM – 09:00 AMClinical Challenges in HSCT for under 2yr oldStalin Ramprakash,
Revathi Raj, Vikas Dua
08:00 AM – 09:00 AMHSCT for patients with co-morbidityAlok Srivastava,
Sandip Shah, Navin Khattry
09:00 AM – 10:30 AM
(20 min talk & 10 min discussion each) For debate- 10 min talk each and 10 mins discussion
Session V:
Post BMT Monitoring
Session Chair:
Chezhian Subash
09:00 AM – 09:30 AMChimerism/ Split ChimerismAnup Devasia
09:30 AM – 10:00 AMNGS based MRDDharma Chaudhary (for) Vs. Ashish Dixit (against)
10:00 AM – 10:30 AMViral MonitoringReetu Jain
10:30 AM – 12:10 PM
(7 min talk & 5 min discussion each)
Session VI:
Oral Presentations
Session Judges:
Lt. Gen. Velu Nair (Retd),
Brig. Satyaranjan Das,
Gaurav Prakash
10:30 AM – 10:42 AMOutcomes of Autologous Stem Cell Transplantation in NonHodgkin Lymphoma – Experience from a single centre study (Abstract ID: ISBMT_P_002)Kolluru Sai Krishna
10:42 AM – 10:54 AMA pilot randomized controlled trial to assess the impact of Isha Kriya on health-related quality of life in hematopoietic cell transplant recipients (Abstract ID: ISBMT_P_018)Madhu Chopra
10:54 AM – 11:06 AMCytomegalovirus reactivation as a risk factor for all-cause mortality in children undergoing hematopoietic stem cell transplantation: experience over two decades from a tertiary referral centre in India (Abstract ID: ISBMT_P_021)Sohini Chakraborty
11:06 AM – 11:18 AMProspective use of eGVHD app to classify and score Graft Versus Host Disease (GVHD) in a single centre (Abstract ID: ISBMT_P_023)Prashant Chhabra
11:18 AM – 11:30 AMGenital graft versus host disease in children – an underdiagnosed and undertreated entity (Abstract ID: ISBMT_P_024)Kavitha Ganesan
11:30 AM – 11:42 AMHigh dose Methylprednisolone in the management of Veno – Occlusive disease of the liver in Pediatric Hematopoietic Stem cell transplantation recipients (Abstract ID: ISBMT_P_027)Pooja Prakash Mallya
11:42 AM- 11:54 AMExperience of haploidentical stem cell transplantation- Real- world data from a tertiary care centre (Abstract ID: ISBMT_P_028)Akanksha Garg
11:54 AM – 12:06 PMAcute steroid-refractory graft versus host disease in children: Are we salvaging it well (Abstract ID: ISBMT_P_033)Minakshi Bansal
12:10 PM – 01:10 PMSponsored Symposium (Johnson and Johnson)
12:10 PM – 12:35 PMHIGH Risk Myeloma in FrontlineDeepesh Lad
12:35 PM – 01:10 PMPanel Discussion
Case based discussion – HIGH Risk Myeloma in Frontline
Moderator
Bhausaheb Bagal
Panelists
Dinesh Bhurani
Neeraj Sidharthan
Rishi Dhawan
Joydeep Chakraborty
01:10 PM – 01:30 PMBreak
01:30 PM – 03:00 PM
(20 min talk & 10 min discussion each)
Session VII:
Microbes and More
Session Chair:
Dinesh Bhurani
01:30 PM – 02:00 PMAntibiotics StewardshipJoseph John
02:00 PM – 02:30 PMFecal Microbial therapyParikshit Prayag
02:30 PM – 03:00 PMTropical infections in India post HSCTRayaz Ahmed
03:00 PM – 05:00 PMISBMT Members Session
(Only for ISBMT Members)
Moderators:
Mammen Chandy
Alok Srivastava
03:00 PM – 03:30 PMISBMT Registry Data 2021Alok Srivastava
03:30 PM – 04:00 PMData collection processes and plans – Way forward including analysis/ publication of aggregate activity dataA. Rajagopal
04:00 PM – 04:30 PMWorking groups in ISBMTSharat Damodar
04:30 PM – 05:00 PMAPBMT 2022 – UpdateShashikant Apte,
Navin Khattry
05:00 PM – 05:15 PMClosing Remarks